Kezar Life Sciences, Inc. · NASDAQ:KZR
Kirk Christopher J. reported 1 trade in Kezar Life Sciences, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Kirk Christopher J. (Director, CEO) reported 1 trade in Kezar Life Sciences, Inc. shares, leaving 0 shares. Filed May 11, 2026 (Form 4).
- Shares
- 43,134 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Other | 43,134 | 0 | Direct |
Source
Related
- Kezar Life Sciences, Inc.
- Kirk Christopher J.
- Kezar Life Sciences, Inc. shareholders
- Schedule 13G/A · Baselake Partners, LP · May 28, 2026
- Schedule 13D/A · Tang Capital Management LLC · May 13, 2026
- Schedule 13G/A · Baselake Partners, LP · May 12, 2026
- Form 4 · Schiller Mark C. · May 11, 2026
- Form 4 · Kauffman Michael · May 11, 2026